AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D

Cancer Research

Volumn 71, Issue 22, 2011, Pages 7091-7102

  Dumartin, Laurent ^a   Whiteman, Hannah J ^a   Weeks, Mark E ^e   Hariharan, Deepak ^a   Dmitrovic, Branko ^f   Iacobuzio Donahue, Christine A ^g   Brentnall, Teresa A ^h   Bronner, Mary P ⁱ   Feakins, Roger M ^c   Timms, John F ^d   Brennan, Caroline ^b   Lemoine, Nicholas R ^a   Crnogorac Jurcevic, Tatjana ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e VETERINARY LABORATORIES AGENCY   (United Kingdom)

^f Johns Hopkins Medical Institutions ^*  (Croatia)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR GRADIENT 2 ANTIGEN; CATHEPSIN B; CATHEPSIN D; CHAPERONE; MEMBRANE ANTIGEN; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INVASION; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DISEASE ACTIVITY; EMBRYO; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; PANCREAS CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN TARGETING; REGULATORY MECHANISM; TUMOR CELL; ZEBRA FISH;

ADENOCARCINOMA; ANIMALS; ANTIGENS, SURFACE; CARCINOMA, PANCREATIC DUCTAL; CATHEPSIN B; CATHEPSIN D; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; HUMANS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROTEINS; PROTEOME; ZEBRAFISH;

EID: 81155126043     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1367     Document Type: Article

References (50)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Barraclough DL, Platt-Higgins A, de Silva Rudland S, Barraclough R, Winstanley J, West CR, et al. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. Am J Pathol 2009;175:1848-57.
3. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 2005;65:3796-805. (Pubitemid 40616358)
4. Fritzsche FR, Dahl E, Dankof A, Burkhardt M, Pahl S, Petersen I, et al. Expression of AGR2 in non small cell lung cancer. Histol Histopathol 2007;22:703-8. (Pubitemid 47034136)
5. Park K, Chung YJ, So H, Kim K, Park J, Oh M, et al. AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med 2011;43:91-100.
6. Pohler E, Craig AL, Cotton J, Lawrie L, Dillon JF, Ross P, et al. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteomics 2004;3:534-47. (Pubitemid 38878513)
7. Zhang JS, Gong A, Cheville JC, Smith DI, Young CY. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 2005;43:249-59. (Pubitemid 40726870)
8. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005;65:4993-97. (Pubitemid 40827303)
9. Sitek B, Sipos B, Alkatout I, Poschmann G, Stephan C, Schulenborg T, et al. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation. J Proteome Res 2009;8:1647-56.
10. Ramachandran V, Arumugam T, Wang H, Logsdon CD. Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res 2008;68:7811-18.
11. Persson S, Rosenquist M, Knoblach B, Khosravi-Far R, Sommarin M, Michalak M, et al. Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and Hag3 as novel members of the protein family. Mol Phylogenet Evol 2005;36:734-40. (Pubitemid 41138906)
12. Park SW, Zhen G, Verhaeghe C, Nakagami Y, Nguyenvu LT, Barczak AJ, et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc Natl Acad Sci U S A 2009;106: 6950-5.
13. Liu N, Furukawa T, Kobari M, Tsao MS. Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma. Am J Pathol 1998;153:263-9. (Pubitemid 28317529)
14. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, et al. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 2007;67:8633-42. (Pubitemid 47437439)
15. Weeks ME, Sinclair J, Butt A, Chung YL,Worthington JL, Wilkinson CR, et al. A parallel proteomic and metabolomic analysis of the hydrogen peroxide- and Sty1p-dependent stress response in Schizosaccharomyces pombe. Proteomics 2006;6:2772-96.
16. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004;64:9018-26. (Pubitemid 39665512)
17. Grønborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006;5: 157-71. (Pubitemid 43169348)
18. Elsasser HP, Lehr U, Agricola B, Kern HF. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1992;61:295-306.
19. Sloane BF, Rozhin J, Hatfield JS, Crissman JD, Honn KV. Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol 1987;55:209-24. (Pubitemid 18019796)
20. Missiaglia E, Blaveri E, Terris B,WangYH,Costello E, Neoptolemos JP, et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 2004;112:100-12. (Pubitemid 39249497)
21. Thompson DA, Weigel RJ. hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. Biochem Biophys Res Commun 1998;251:111-16. (Pubitemid 28498072)
22. Altmeyer A, Maki RG, Feldweg AM, Heike M, Protopopov VP, Masur SK, et al. Tumor-specific cell surface expression of the-KDEL containing, endoplasmic reticular heat shock protein gp96. Int J Cancer 1996;69:340-9. (Pubitemid 26298302)
23. Jordan PA, Gibbins JM. Extracellular disulfide exchange and the regulation of cellular function. Antioxid Redox Signal 2006;8: 312-24. (Pubitemid 43741302)
24. Carter P, Smith L, Ryan M. Identification and validation of cell surface antigens for antibody targeting in oncology. Endocr Relat Cancer 2004;11:659-87. (Pubitemid 40065544)
25. Turano C, Coppari S, Altieri F, Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol 2002;193: 154-63.
26. Couët J, de Bernard S, Loosfelt H, Saunier B, Milgrom E, Misrahi M, et al. Cell surface protein disulfide-isomerase is involved in the shedding of human thyrotropin receptor ectodomain. Biochemistry 1996;35:14800-5.
27. Lahav J, Gofer-Dadosh N, Luboshitz J, Hess O, Shaklai M. Protein disulfide isomerase mediates integrin-dependent adhesion. FEBS Lett 2000;475:89-92. (Pubitemid 30365056)
28. Willems SH, Tape CJ, Stanley PL, Taylor NA, Mills IG, Neal DE, et al. Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem J 2010;428:439-50.
29. Chen R, Pan S, Duan X, Nelson BH, Sahota RA, de Rham S, et al. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia. Mol Cancer 2010;9:149.
30. Fonseca C, Soiffer R, Ho V, Vanneman M, Jinushi M, Ritz J, et al. Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction. Blood 2009;113:1681-8.
31. Zhao F, Edwards R, Dizon D, Afrasiabi K, Mastroianni JR, Geyfman M, et al. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice. Dev Biol 2010;338: 270-9.
32. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 2007;67: 10631-4. (Pubitemid 350145884)
33. Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D, et al. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res 2008;68:5363-9.
34. Honore B, Vorum H. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 2000;466:11-8. (Pubitemid 30050674)
35. Tyedmers J, Lerner M, Nastainczyk W, Zimmermann R. Calumenin and reticulocalbin are associated with the protein translocase of the mammalian endoplasmic reticulum. J Biol Sci 2005;5:70-5.
36. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in theMAPKpathway. Nat Cell Biol 2006;8:1053-63. (Pubitemid 44473600)
37. Goplen D, Wang J, Enger PØ, Tysnes BB, Terzis AJ, Laerum OD, et al. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res 2006;66:9895-902. (Pubitemid 44672041)
38. Tumminello FM, Leto G, Pizzolanti G, Candiloro V, Crescimanno M, Crosta L, et al. Cathepsin D, B and L circulating levels as prognostic markers of malignant progression. Anticancer Res 1996;16: 2315-9. (Pubitemid 26265584)
39. Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003;162:1151-62. (Pubitemid 36350660)
40. Rao JS. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003;3:489-501. (Pubitemid 37328837)
41. Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004;5:443-53. (Pubitemid 38610246)
42. Tzanakakis GN, Margioris AN, Tsatsakis AM, Vezeridis MP. The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsinBactivity. Int J Gastrointest Cancer 2003;34:27-38. (Pubitemid 38962758)
43. Davis R, Schooley K, Rasmussen B, Thomas J, Reddy P. Effect of PDI overexpression on recombinant protein secretion in CHO cells. Biotechnol Prog 2000;16:736-43.
44. Robinson AS, Hines V, Wittrup KD. Protein disulfide isomerase over-expression increases secretion of foreign proteins in Saccharomyces cerevisiae. Biotechnology (N Y) 1994;12:381-4.
45. Gole B, Duran Alonso MB, Dolenc V, Lah T. Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro. Pathol Oncol Res 2009;15:711-23.
46. Baldwin ET, Bhat TN, Gulnik S, Hosur MV, Sowder RC, Cachau RE, et al. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc Natl Acad Sci U S A 1993;90:6796-800. (Pubitemid 23207300)
47. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 2009;9:128.
48. Capony F, Rougeot C, Montcourrier P, Cavailles V, Salazar G, Rochefort H, et al. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Cancer Res 1989;49:3904-9. (Pubitemid 19197419)
49. Brouillet JP, Dufour F, Lemamy G, Garcia M, Schlup N, Grenier J, et al. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immuno-assay. Cancer 1997;79:2132-6. (Pubitemid 27227377)
50. Taylor DD, Gercel-Taylor C. Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review). Oncol Rep 1998;5:1519-24. (Pubitemid 28474105)